FAGR 📈 Fagron - Overview
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003874915
FAGR: Pharmaceuticals, Excipients, Hair care products, Skincare products, Capsules
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium. Web URL: https://www.fagron.com
Additional Sources for FAGR Stock
FAGR Stock Overview
| Market Cap in USD | 1,394m |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| GiC Sub-Industry | Pharmaceuticals |
| IPO / Inception |
FAGR Stock Ratings
| Growth 5y | 3.92% |
| Fundamental | 74.2% |
| Dividend | 56.4% |
| Rel. Strength Industry | 411 |
| Analysts | - |
| Fair Price Momentum | 17.18 EUR |
| Fair Price DCF | 32.06 EUR |
FAGR Dividends
| Dividend Yield 12m | 1.64% |
| Yield on Cost 5y | 1.65% |
| Annual Growth 5y | 15.81% |
| Payout Consistency | 80.2% |
FAGR Growth Ratios
| Growth Correlation 3m | -16.2% |
| Growth Correlation 12m | 71.5% |
| Growth Correlation 5y | -21.7% |
| CAGR 5y | -0.08% |
| CAGR/Mean DD 5y | 0.00 |
| Sharpe Ratio 12m | 0.31 |
| Alpha | -8.14 |
| Beta | 0.57 |
| Volatility | 18.97% |
| Current Volume | 228.9k |
| Average Volume 20d | 57.6k |
What is the price of FAGR stocks?
As of December 22, 2024, the stock is trading at EUR 18.12 with a total of 228,863 shares traded.
Over the past week, the price has changed by -1.08%, over one month by +0.77%, over three months by -2.88% and over the past year by +11.92%.
As of December 22, 2024, the stock is trading at EUR 18.12 with a total of 228,863 shares traded.
Over the past week, the price has changed by -1.08%, over one month by +0.77%, over three months by -2.88% and over the past year by +11.92%.
Is Fagron a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Fagron (BR:FAGR) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 74.17 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FAGR as of December 2024 is 17.18. This means that FAGR is currently overvalued and has a potential downside of -5.19%.
Yes, based on ValueRay Fundamental Analyses, Fagron (BR:FAGR) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 74.17 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FAGR as of December 2024 is 17.18. This means that FAGR is currently overvalued and has a potential downside of -5.19%.
Is FAGR a buy, sell or hold?
Fagron has no consensus analysts rating.
Fagron has no consensus analysts rating.
What are the forecast for FAGR stock price target?
According to ValueRays Forecast Model, FAGR Fagron will be worth about 18.8 in December 2025. The stock is currently trading at 18.12. This means that the stock has a potential upside of +3.53%.
According to ValueRays Forecast Model, FAGR Fagron will be worth about 18.8 in December 2025. The stock is currently trading at 18.12. This means that the stock has a potential upside of +3.53%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 22.2 | 22.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 18.8 | 3.5% |